
TOKYO -- Takeda Pharmaceutical CEO Christophe Weber promised greater cost savings from the company's purchase of Irish drugmaker Shire, lifting the savings target by 43% versus its earlier forecast.
Japanese drugmaker forecasts sales jump and lower profit in 'critical' 2019
TOKYO -- Takeda Pharmaceutical CEO Christophe Weber promised greater cost savings from the company's purchase of Irish drugmaker Shire, lifting the savings target by 43% versus its earlier forecast.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.